Lantana camara: A Comprehensive Reference
1. Identity and Botanical Overview
1.1 Taxonomy and Nomenclature
Lantana camara (common lantana) is a species of flowering plant in the verbena family (Verbenaceae), native to the tropics of the Americas. The genus Lantana as described by Linnaeus in 1753 contained seven species, six from South America and one from Ethiopia. Lantana camara L., commonly known as wild or red sage, is the most widespread species of this genus. The genus is taxonomically difficult to classify since species are not stable and hybridisation is widespread, shape of inflorescence changes with age, and flower colours vary with age and maturity.
The plant is also known as big-sage (Malaysia), wild-sage, red-sage, white-sage (Caribbean), and tickberry (South Africa). In the Ayurvedic medicinal system, it is known by the Sanskrit names of Chaturangi and Vanacchedi. In Brazil, it is popularly known as camará or chumbinho.
1.2 Morphology and Distribution
Lantana camara L. is a perennial shrub, 1–4 m in height, with quadrangular or cylindrical stems and small prickles. Multiple stems frequently arise at the base of the main stems and form dense impenetrable stands. The oval leaves are opposite and serrate. The flowers, borne in flat-topped clusters, are small, tubular, and white, yellow, orange, red, or purple in colour. The fruits are produced in clusters and turn black when ripe.
It is a very adaptable species, which can inhabit a wide variety of ecosystems; once introduced into a habitat it spreads rapidly, between 45°N and 45°S and less than 1,400 metres in altitude. It has spread from its native range to around 50 countries, where it has become an invasive species. L. camara has spread across tropical, subtropical, and temperate regions in Asia, Africa, Oceania, North and South America, and Europe, and its population increases aggressively as one of the world's 100 worst invasive alien species.
1.3 Common Forms and Preparations
The plant is widely used in different traditional medical practices for treating various health problems, and different parts of the plant are used in treating various human ailments such as measles, chicken pox, tetanus, malaria, cancers, asthma, ulcers, fevers, eczema, skin rashes, cardiac disorders, and rheumatism. Preparations documented in the ethnobotanical literature include aqueous decoctions or infusions of the leaves, leaf poultices applied topically to wounds and skin conditions, ethanolic and methanolic leaf extracts prepared for laboratory research, and steam-distilled essential oils from the leaves, flowers, and stems. The essential oil is also available commercially under the name "Lantana oil."
2. Traditional and Historical Use
2.1 Americas (Region of Origin)
People are using Lantana across the globe for diverse purposes, among which its role in ethnomedicine is well-known. For example, Lantana has been reported as one of the 44 major plant species utilized by traditional healers of Zapotitlán de las Salinas, Puebla, in México to treat gastrointestinal diseases. In popular medicine, both Lantana camara and related species are used as carminative, antispasmodic, antiemetic, and to treat respiratory infections such as cough, cold, asthma, and bronchitis.
2.2 South Asia (India and the Subcontinent)
In India, L. camara arrived as an ornamental plant. It later spread across roadsides, railway tracks, edges of crop fields, and open forests all over the country, and is now naturalized throughout India. It is well known in the Ayurvedic medicinal system. Different parts of the plant are used as traditional remedies for the treatment of various human ailments, such as itches, cuts, ulcers, swellings, bilious fever, catarrh, asthma and bronchitis, eczema, chicken pox, tetanus, malaria, tumors, stomachache, toothache, headache, scabies, leprosy, rheumatism, and as an antiseptic agent to treat wounds.
2.3 Africa
In Africa, an infusion of the leaves is used to address rheumatism, asthma, coughs, and colds. Used in traditional medicine systems in Africa, India, Southeast Asia, and the Caribbean, different parts of the lantana plant — especially its leaves, flowers, and roots — are known for their antimicrobial, anti-inflammatory, and analgesic properties.
2.4 Pakistan and Other South Asian Regions
In Hafizabad District, Punjab, Pakistan, leaf, flower, and root extracts of Lantana are used by local people for the treatment of headache, ringworm, injuries, toothache, and malaria.
2.5 Scope of Ethnomedicinal Use
Lantana camara, a common invasive weed, has developed a plethora of traditional medicinal uses. It is presently used as folk medicine for various ailments, including inflammation, pain, infections, fever, and respiratory issues, and it has a lofty place in traditional folk medicine as an antimalarial agent, where indigenous people rely on the use of Lantana camara with confidence. It has also been used in traditional herbal medicines for treating a variety of ailments, including cancer, skin itches, leprosy, chicken pox, measles, asthma, and ulcers.
3. Key Constituents and Active Compounds
3.1 Overall Phytochemical Profile
Phytochemical studies conducted by different research groups have led to the isolation of essential oils, various steroids, terpenoids, saponins, iridoids, flavonoids, phenylethanoids, naphthoquinones, coumarins, polyphenols and other phenolics, and alkaloids. Interestingly, the genus Lantana is free of diterpenoids. A total of 168 compounds have been described with different names in the considered period, including both specialized metabolites isolated from non-volatile fractions of L. camara as well as semisynthetic derivatives.
3.2 Triterpenoids (Lantadenes)
Lantadenes are naturally occurring pentacyclic triterpenoids found in the Lantana camara plant. They are known to be poisonous to livestock that graze on the leaves of the plant, causing photosensitivity and hepatotoxicity as major symptoms. Lantadenes A and B are the most abundant and bioactive triterpenoids found in the Lantana camara leaves. There are four types of lantana leaf toxins: lantadene A (LA), lantadene B (LB), lantadene C (LC), and lantadene D (LD). Six compounds isolated from leaves of Lantana camara have been identified by chemical and spectral analysis, including oleanonic acid, lantadene A, lantadene B, lantanilic acid, and icterogenin. The two major chemical compounds isolated from Lantana are lantadene A and B. These two compounds are responsible for many of the pharmacological activities reported from Lantana.
3.3 Flavonoids
Secondary metabolites including alkaloids, glycosides, steroids, saponins, flavonoids, isoflavonoids, flavones, lignans, catechin, phenolic acids, iridoids, coumarins, tannins, triterpenes, phenyl ethanoid glycosides, carbohydrates, anthraquinones, anthraquinone glycosides, fatty acids, and proteins are attributed to its medicinal properties. Among the specific flavonoids isolated, quercetin, luteolin, and apigenin have been documented. Methanolic leaf extracts have been found to contain the highest phenolic (92.8 mg GAE/g) and flavonoid (26.5 mg RE/g) content relative to other solvent extracts.
3.4 Iridoid Glycosides
Six iridoid glucosides isolated from the ethanolic extract of L. camara roots have been identified as theveside, 8-epiloganin, shanzhsid methyl ester, theviridoside, lamiridoside, and geniposide. Two new oligosaccharides named lantanose A and lantanose B were also identified.
3.5 Essential Oil Constituents
The compositions of essential oil obtained from leaves, flowers, and fruits of Lantana camara have been investigated by GC and 13C NMR. GC/MS analysis of L. camara's leaf essential oil revealed the composition of phytoconstituents as germacrene D (6.9%), (E)-β-caryophyllene (40.8%), α-humulene (21.2%), sabinene (9.0%), bicyclogermacrene (7.9%), α-pinene (4.4%), and β-elemene (3.5%). The chemical composition of leaves and flowers essential oils of L. camara from India, analysed by GC and GC–MS, resulted in the identification of 71 and 64 constituents respectively. The major constituents in the leaf oil were germacrene-D (20.5%), γ-elemene (10.3%), β-caryophyllene (9.4%), β-elemene (7.3%), α-copaene (5.0%), and α-cadinene (3.3%). Comparison with the chemical composition of L. camara oils of different geographical origin showed significant differences with respect to their major constituents.
Flower essential oils from L. camara are most frequently dominated by (E)-β-caryophyllene (19.2–36.6%) and α-humulene (8.5–19.9%).
3.6 Other Notable Compounds
Caryophyllene oxide, spathulenol, and germacrene-D are known to possess anticarcinogenic, anti-inflammatory, and antibacterial properties. Hexadecanoic acid, a major phytoconstituent of L. camara methanolic leaf extract, is known to possess strong antimicrobial activity. Phytol, another important compound, is reported with antioxidant, cytotoxic, and antimicrobial properties.
4. Mechanisms of Action
4.1 Anti-Inflammatory Mechanisms
Plant extracts have been reported to inhibit the enzymes acetylcholinesterase, alpha-amylase, carboxylesterase, cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), glutathione-S-transferase (GST), 5-lipoxygenase (5-LOX), protein kinase C, and xanthine oxidase. Network pharmacology analysis identified the top five key proteins involved in L. camara's anti-inflammatory activity, including peroxisome proliferator-activated receptor gamma (PPAR-γ) and prostaglandin G/H synthase 2 (COX-2).
4.2 Anticancer Mechanisms
Lupeol, found in L. camara, produces its anticancer effects by altering important signalling pathways such as PI3K/Akt, MAPK/ERK, and JAK/STAT and controlling the activity of proteins that promote cell cycle progression or apoptosis. The phytol found in L. camara leaf extract was found to have anticancer action by blocking the PI3K-Akt signalling pathway.
4.3 Antioxidant Mechanisms
Four distinct varieties of L. camara, whose leaves are rich in phenolic compounds, have been extracted with methanol and shown to have strong antioxidant, free radical scavenging, and in vitro lipid peroxidation inhibition properties. In vitro analysis showed that extracts inhibited protein activity and protein denaturation with IC50 values of 202.27 and 223.85 ppm respectively. Additionally, the extract had antioxidant activity with DPPH- and ABTS-scavenging IC50 values of 140 ppm and 163 ppm respectively.
4.4 Antimicrobial Mechanisms
Hexadecanoic acid and certain related compounds have potent anti-inflammatory properties by blocking TNF-α, a major contributor to inflammation. Studies of the antibacterial activity of ethanolic extracts of L. camara leaves and roots against gram-positive and gram-negative strains have used the microdilution method to determine minimal inhibitory concentration (MIC).
5. Scientific Evidence by Area of Use
5.1 Antimicrobial and Antibacterial Activity
Evidence strength: Moderate (primarily in vitro; some animal studies; no human clinical trials identified).
The purpose of one published study was to evaluate the in vitro antibacterial activity of ethanolic extracts from L. camara leaves and roots using the microdilution method to assay the susceptibilities of five bacteria strains (American Type Culture Collection — ATCC) and two multi-resistant strains isolated from clinical material. The extracts demonstrated antibacterial activity against all tested bacteria.
Antimicrobial efficacy of flavonoids and crude alkaloids of L. camara was determined by disc diffusion assay against three bacteria (Escherichia coli, Proteus mirabilis, and Staphylococcus aureus) and two fungi (Candida albicans and Trichophyton mentagrophytes). Minimum inhibitory concentration (MIC), minimum bactericidal/fungicidal concentration (MBC/MFC) and total activity were studied. The most susceptible microorganism was C. albicans followed by P. mirabilis, S. aureus, E. coli, and T. mentagrophytes. The range of MIC of tested extracts was 0.039–0.625 mg/mL while MBC/MFC ranged from 0.078–1.25 mg/mL.
Methanol leaf extract has been shown to have a significantly higher antimicrobial potential than ethanol and water leaf extracts. All antimicrobial studies to date have been conducted in vitro or in laboratory models; no randomised controlled human clinical trials have been published.
5.2 Anti-Inflammatory Activity
Evidence strength: Preliminary (in vitro and network pharmacology; no human trials identified).
One study evaluated the potential of L. camara leaves collected at the Ie-Seu'um geothermal area in Aceh, Indonesia, as an anti-inflammatory through network pharmacology and in vitro analysis. The ethanolic extract was identified using GC-MS, and anti-inflammatory activity was evaluated using protein inhibition and albumin denaturation assays. The findings revealed that the extract contained a domination of terpenoids and fatty acids, which met evaluation criteria of drug-likeness. Toxicological assessment by brine shrimp lethality assay (BSLA) yielded a lethal concentration (LC50) value of 574 ppm, considered essentially non-toxic, and prediction via ProTox 3.0 indicated non-active in hepatotoxicity, carcinogenicity, immunotoxicity, mutagenicity, and cytotoxicity. These results suggested that L. camara holds noteworthy effectiveness as a potential candidate for complementary medicine in the realm of inflammatory agents, warranting further investigation in clinical settings.
5.3 Antioxidant Activity
Evidence strength: Preliminary (in vitro only; variety- and solvent-dependent results).
One published study investigated the content of total phenolics, flavonoids and the antioxidant activity of four different varieties of Lantana camara L. (Verbenaceae) leaves using in vitro antioxidant models. The leaves of Chandigarh purple variety (CPV), Palampur red variety (PRV), Chandigarh yellow turning pink variety (YTPV), and Chandigarh yellow variety (CYV) were assessed. The phenolic content was found to be highest in the CYV extract (232.99 ± 15.97 mg GAE/g extract). DPPH radical scavenging assay showed the IC50 value of 165, 200, 245, and 440 μg/mL for methanol, ethyl acetate, acetone, and chloroform extracts respectively. The hydroxyl scavenging activity test showed the IC50 value of 110, 240, 300, and 510 μg/mL for the same solvents respectively. These findings are wholly in vitro.
5.4 Anticancer and Antiproliferative Activity
Evidence strength: Preliminary (in vitro cell-line studies only; no animal or human trials identified).
Triterpenes, flavonoids, phenylpropanoids, and iridoid glycosides are the bioactive compounds naturally occurring in L. camara that have demonstrated anticancer, antifilarial, nematocidal, antibacterial, insecticidal, antileishmanial, antifungal, anti-inflammatory, and antioxidant properties.
Extracts of L. camara leaves have been reported to exhibit cytotoxicity effects and antiproliferative activity against HEp-2 (laryngeal cancer) and NCI-H292 (lung cancer) cell lines, with the in vitro antiproliferative test performed by MTT assay. Methanol extract of L. camara leaves exhibited antiproliferative activity against NCI-H292 cells. Ethanolic extract exhibited significant antioxidant activity in in vivo studies. All published anticancer data pertain to cell-line experiments and animal models; no human clinical trials have been conducted.
5.5 Wound Healing
Evidence strength: Preliminary (animal preclinical studies only).
One published preclinical study investigated the excision wound healing activity of the leaf extract of L. camara in rats. The animals were divided into two groups of 12 each. The test group animals were treated with the aqueous extract of L. camara at 100 mg/kg/day topically and the control group animals were left untreated. Wound healing efficacy was measured by determining the morphological and biochemical parameters, including wound healing time, wound contraction, and synthesis of collagen. Antimicrobial activities of the extract against microorganisms were also assessed. Treatment of the wounds with extract enhanced significantly the rate of wound contraction (98%), synthesis of collagen, and decreased mean wound healing time. These results are preclinical; no human studies have been published.
5.6 Antidiabetic Activity
Evidence strength: Preliminary (in vitro and animal studies only).
Leaf extracts and essential oil of L. camara leaves have been reported to possess antidiabetic and hypolipidemic properties, among other pharmacological activities. Inhibition of alpha-amylase and alpha-glucosidase enzymes relevant to glucose metabolism has been reported in in vitro assays. No human clinical trials have been identified for antidiabetic endpoints.
5.7 Antiulcer Activity
Evidence strength: Preliminary (animal models only).
The methanolic extract of Lantana camara leaves has been shown to facilitate healing of gastric ulcers and also to prevent development of duodenal ulcers in rats. L. camara extract has shown ability to reduce gastric ulcer development in rats. No human clinical data are available.
5.8 Antimalarial Activity
Evidence strength: Preliminary (in vivo animal studies; no controlled human trials identified).
Lantana camara holds a lofty place in traditional folk medicine as an antimalarial agent, where indigenous people rely on its use with confidence. Phytochemical investigations have linked this activity to the terpenoid and flavonoid fractions. In vitro antimalarial assays and some animal experiments have been published, but no rigorous human clinical trial evidence is available.
5.9 Antifilarial Activity
L. camara has been found to display antiarthritic, anti-aspergillus, antibacterial, anticancer, cardioactive, anti-fertility, antifilarial, hepatoprotective, anti-hyperglycemic, anti-hyperlipidemic, anti-inflammatory, insecticidal, antimicrobial, antimutagenic, anxiolytic, nematocidal, antioxidant, anti-proliferative, anti-protozoal, antipyretic, antithrombin, antitumor, antiulcerogenic, antiurolithiasis, antiviral, and wound-healing properties in laboratory or animal investigations. Antifilarial activity has been specifically demonstrated against the human lymphatic filarial parasite Brugia malayi in preclinical models. No human clinical trials for filarial disease have been identified.
5.10 Insecticidal and Mosquito Repellent Activity
The essential oil has shown antibacterial, antifungal, cytotoxic, and mosquito-repellent effects. As a biofumigant, coumaran derived from L. camara leaves is reported to act against insect pests found in stored food grains. These activities are established primarily through laboratory and semi-field studies.
6. Body Systems and Health Areas of Association
- Integumentary system (skin): Traditional use for wounds, cuts, scabies, leprosy, eczema, ringworm, chicken pox, and measles; supported by preclinical wound-healing data.
- Gastrointestinal system: Traditional use for stomachache, gastrointestinal ailments, and antiulcer applications; supported by animal studies showing reduction in gastric ulcer formation.
- Respiratory system: Traditional use for cough, cold, asthma, and bronchitis across multiple cultures; no clinical trial evidence.
- Immune and infectious disease: Antimalarial, antibacterial, antifungal, and antiprotozoal applications; supported by in vitro and some animal data.
- Oncology (experimental): In vitro antiproliferative and cytotoxic activity against several cancer cell lines; no clinical evidence.
- Endocrine/metabolic: Antidiabetic and hypolipidemic effects reported in cell and animal models; no human data.
- Musculoskeletal: Traditional use for rheumatism and headache; in vitro anti-inflammatory data partially supporting these uses.
- Hepatic system: The plant's triterpenoid constituents (lantadenes) are hepatotoxic in animals; certain isolated fractions have paradoxically been tested for hepatoprotective activity in separate models, illustrating the dose- and fraction-dependent nature of the plant's actions.
7. Dosage Forms and Reported Dosages
No standardised therapeutic dosage for human use has been established. The following dosages have appeared in preclinical or pharmacological studies:
- In a rat wound healing study, the aqueous extract of L. camara was administered at 100 mg/kg/day topically.
- In antimicrobial assays, the range of minimum inhibitory concentration (MIC) of tested extracts was 0.039–0.625 mg/mL, while minimum bactericidal/fungicidal concentration ranged from 0.078–1.25 mg/mL.
- In antioxidant studies, methanol extracts recovered 14.4% yield and showed DPPH IC50 values of 165 μg/mL.
- In one in vitro study, cell cytotoxicity (CC50) of L. camara extract was found to be 382.5 µg/mL.
Traditional preparations are typically infusions or decoctions of leaves prepared and administered according to local custom, with no standardised dose. In-depth mechanistic studies and standardisation of extraction methods, dose, as well as clinical studies and detailed toxicological assessments are required to tap the complete potential of plant-based medicines in modern healthcare systems.
8. Safety Considerations and Interactions
8.1 Hepatotoxicity
Ingestion of lantana foliage by grazing animals causes cholestasis and hepatotoxicity. Both ruminants and non-ruminant animals such as guinea pigs, rabbits, and female rats are susceptible to the hepatotoxic action of lantana toxins. The hepatotoxins are pentacyclic triterpenoids called lantadenes A and B. The triterpene acids lantadene A and B induce an intrahepatic cholestasis. Ingestion of L. camara leaves by livestock has been linked to cholestasis and hepatotoxicity, leading to conditions such as jaundice, photosensitivity, and hyperactivity of glutamic oxaloacetic transaminase.
Among the known compounds present in lantana, lantadene A (LA) is the most hepatotoxic. At least 15 of the 29 described taxa of Lantana camara are known to be toxic to livestock. About 1% body weight of green leaves will induce poisoning in animals.
8.2 Human Toxicity
Lantana foliage, which contains hepatotoxic pentacyclic triterpenoids called lantadenes, causes cholestasis and hepatotoxicity in animals, including ruminants and non-ruminants such as guinea pigs, rabbits, and rats; the unripe fruits of the plant are toxic in humans. Green unripe fruits of the plant are toxic to humans. Human case reports of poisoning most frequently involve children who have consumed the berries. Systematic clinical data on human toxicity thresholds are limited.
8.3 Photosensitisation
Lantadenes are pentacyclic triterpenes that cause hepatotoxicity and jaundice, as well as photosensitisation. The lantadenes found primarily in the plant leaves have different harmful effects on different mammals or livestock species. The toxins affect the liver and kidneys of ruminants and lead to photosensitisation.
8.4 Cytotoxic Potential
The identification of bioactive terpenoid constituents, together with observed antioxidant activity, moderate anti-inflammatory effects, and model-dependent cytotoxicity, provides partial pharmacological support for traditional medicinal applications. Importantly, the detection of cytotoxic effects also emphasises the need for careful safety assessment, dose consideration, and route-of-administration evaluation, as these factors may limit certain applications, particularly oral use.
8.5 Animal Management of Toxicosis
Management of lantana toxicosis in animals is achieved by drenching with activated charcoal and supportive therapy. No equivalent validated treatment protocol for human lantana poisoning has been established in the clinical literature reviewed.
8.6 Ecological and Regulatory Status
L. camara is one of the world's 100 worst invasive alien species. Its infestation reduces species diversity and abundance in the natural ecosystems and reduces agricultural production. The plant is not approved by any major regulatory pharmacopeia (including WHO, EMA, or USP) as a therapeutic agent for human use, and no official monograph defining a therapeutic dose exists. All research findings discussed in the scientific literature remain at the preclinical stage.
9. Summary of Evidence Quality
The broad scientific interest in Lantana camara as a medicinal plant is supported by an extensive base of in vitro and animal studies demonstrating antimicrobial, anti-inflammatory, antioxidant, antiproliferative, wound-healing, and other pharmacological activities. Despite being categorised as an invasive species, it has been used for a long time to treat different diseases thanks to the many biological activities. However, the field currently lacks controlled human clinical trials for any indication. The collective findings contribute mechanistic and experimental evidence that helps to contextualise the ethnomedicinal use of L. camara and support a more rational, evidence-based, and informed utilisation of this species — but translation to clinical medicine requires substantially more rigorous investigation. The documented hepatotoxicity of its principal triterpenoids in multiple animal species, and the confirmed toxicity of its unripe fruits in humans, represent well-established safety concerns that must be weighed against any potential therapeutic application.
References
- Ramírez J, Armijos C, et al. "Ethnobotany, Phytochemistry, and Biological Activity of Extracts and Non-Volatile Compounds from Lantana camara L. and Semisynthetic Derivatives — An Updated Review." Molecules. 2025 Feb;30(4):851. PMC11858648.
- Lantana camara L.: A Review of its Traditional Uses, Phytochemistry, Pharmacological Activities, and Toxicology. Tropical Plant Taxonomy, 2025.
- "Studies on the Chemical Constituents of the Leaves of Lantana camara." PubMed PMID 8328268.
- "Studies on Chemical Constituents of the Roots of Lantana camara." PubMed PMID 1442083.
- Exploring the Medicinal Potential of Lantana camara: A Comprehensive Review of Phytochemicals and Therapeutic Application. Phytochemistry Reviews, Springer, 2025.
- Mahdi-Pour B et al. "In Vitro Pharmacological Activities and GC-MS Analysis of Different Solvent Extracts of Lantana camara Leaves Collected from Tropical Region of Malaysia." PMC4689920.
- "Uncovering Anti-Inflammatory Potential of Lantana camara Linn: Network Pharmacology and In Vitro Studies." PMC11391997.
- "Unveiling the Phytochemical Profile and Anti-Cancer Potential of Lantana camara Leaf and Root Extracts Against MCF-7, HepG2, and A549 Cancer Cell Lines." PMC12424060.
- "Antibacterial Activity of Lantana camara Linn and Lantana montevidensis Brig Extracts from Cariri-Ceará, Brazil." PMC3035883.
- "Chemical Composition and Resistance-Modifying Effect of the Essential Oil of Lantana camara Linn." PMC2900066.
- "Bioefficacy of Lantana camara L. against Some Human Pathogens." PMC2866360.
- "Evaluation of Wound Healing Activity of Lantana camara L. — A Preclinical Study." PubMed PMID 18844241.
- "Evaluation of Antioxidant Activity and Total Phenol in Different Varieties of Lantana camara Leaves." PMC4156633.
- "Phytochemical Screening, Antioxidants and Antimicrobial Potential of Lantana camara in Different Solvents." PMC4027341.
- "A Review of the Hepatotoxic Plant Lantana camara." PubMed PMID 17453937.
- Lantadene — Wikipedia (for chemical identity and history of isolation).
- Lantana — ScienceDirect Topics overview (pharmacology and toxicology).
- Lantana camara: Poisonous Species and a Potential Browse Species for Goats in Southern Africa — A Review. MDPI Sustainability. 2022.
- Comprehensive Characterization of Lantana camara Essential Oil from Angola: GC-MS Profiling, Antioxidant Capacity, and Drug-likeness Prediction. MDPI Antioxidants. 2026.
- Khan M et al. "Chemical Composition of Leaf and Flower Essential Oil of Lantana camara from India." Flavour and Fragrance Journal. 2002.
- "Composition, Seasonal Variation, and Biological Activities of Lantana camara Essential Oils from Côte d'Ivoire." PMC7287757.
- "Lantana camara Ethanolic Leaves Extracts Exhibit Anti-Aging Properties in Drosophila melanogaster." PMC7885186.
- Ghisalberti EL. "Lantana camara L. (Verbenaceae)." Fitoterapia. 2000;71(5):467–86. ScienceDirect.
- Traditional Medicinal Uses and Scientific Validation of Lantana camara. Springer Nature.
- Ramya NS et al. "Lantana camara — Ethnobotanical Review." International Journal of Research in Ayurveda and Pharmacy. 13(6), 2022.
- Lantana camara — Wikipedia.
- Phytocompound Profiling and GC-MS Analysis of Lantana camara Leaf Extract. ScienceDirect, 2024.
- Lantana camara L. — Guide to Poisonous Plants. Colorado State University College of Veterinary Medicine and Biomedical Sciences.